Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Geography in multiple sclerosis.
Polymorphism in Leptin and Leptin Receptor Genes May Modify Leptin Levels and Represent Risk Factors for Multiple Sclerosis.
VLA-4/CD49d downregulated on primed T lymphocytes during interferon-beta therapy in multiple sclerosis.
Treatment Options to Reduce Disease Activity After Natalizumab: Paradoxical Effects of Corticosteroids.
Tolerability and Pulmonary Pharmacodynamic Effects During Treatment Initiation of Once-Daily Oral Fingolimod in Subjects With Moderate Asthma.
Treatment with retinoid X receptor agonist IRX4204 ameliorates experimental autoimmune encephalomyelitis.
Antibodies to Interferon beta in Patients with Multiple Sclerosis Receiving CinnoVex, Rebif, and Betaferon.
Multiple sclerosis and chronic progressive external ophthalmoplegia associated with a large scale mitochondrial DNA single deletion.
Evidence for Mitoxantrone-induced Block of Inwardly Rectifying K Channels Expressed in the Osteoclast Precursor RAW 264.7 Cells Differentiated with Lipopolysaccharide.
Effects of fumaric acid esters on blood-brain barrier tight junction proteins.
Long-term genome-wide blood RNA expression profiles yield novel molecular response candidates for IFN-beta-1b treatment in relapsing remitting MS.
Two cases of relapses in primary progressive multiple sclerosis after fingolimod withdrawal.
The cell biology of CNS myelination.
Interferon beta 1a anaphylaxis, a case report. Standardization of non-irritating concentration for allergy skin.
Oral teriflunomide for patients with a first clinical episode suggestive of multiple sclerosis (TOPIC): a randomised, double-blind, placebo-controlled, phase 3 trial.
Daclizumab in multiple sclerosis: a high-yield extension study.
Is No Evidence of Disease Activity a Realistic Goal for Patients With Multiple Sclerosis?
Fumarate treatment in progressive forms of multiple sclerosis: first results of a single-center observational study.
Central fatigue in multiple sclerosis: a review of the literature.
PML in a patient treated with fumaric acid.
Neurological involvement in Primary Sjögren Syndrome.
Results from Two Phase III Studies Added to U.S. Label of Genzyme’s Aubagio
Protein microarrays guide tolerizing DNA vaccine treatment of autoimmune encephalomyelitis.
Teriflunomide effect on immune response to influenza vaccine in patients with multiple sclerosis.
Assessment of cancer risk with β-interferon treatment for multiple sclerosis.

Pages